BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Docket Clock//docket-clock.pages.dev//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:General Considerations for the Use of New Approach Methodolo
X-PUBLISHED-TTL:PT12H
REFRESH-INTERVAL;VALUE=DURATION:PT12H
BEGIN:VEVENT
UID:2026-05390-close@docket-clock.pages.dev
DTSTAMP:20261017T145145Z
DTSTART;VALUE=DATE:20260518
DTEND;VALUE=DATE:20260519
SUMMARY:FDA comments close: General Considerations for the Use of New Appr
 oach Methodologies in Drug Development\; Draft Guidance for Industry\; Av
 ailability
DESCRIPTION:Notice. Federal Register 2026-05390. Docket FDA-2025-D-6131. D
 etails: https://docket-clock.pages.dev/doc/2026-05390/ Official: https://
 www.federalregister.gov/documents/2026/03/19/2026-05390/general-considera
 tions-for-the-use-of-new-approach-methodologies-in-drug-development-draft
 -guidance
URL:https://www.federalregister.gov/documents/2026/03/19/2026-05390/genera
 l-considerations-for-the-use-of-new-approach-methodologies-in-drug-develo
 pment-draft-guidance
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR